{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T13:06:37Z","timestamp":1768741597476,"version":"3.49.0"},"reference-count":52,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The synthetic peptide T11F (TCRVDHRGLTF), with sequence identical to a fragment of the constant region of human IgM, and most of its alanine-substituted derivatives proved to possess a significant candidacidal activity in vitro. In this study, the therapeutic efficacy of T11F, D5A, the derivative most active in vitro, and F11A, characterized by a different conformation, was investigated in Galleria mellonella larvae infected with Candida albicans. A single injection of F11A and D5A derivatives, in contrast with T11F, led to a significant increase in survival of larvae injected with a lethal inoculum of C. albicans cells, in comparison with infected animals treated with saline. Peptide modulation of host immunity upon C. albicans infection was determined by hemocyte analysis and larval histology, highlighting a different immune stimulation by the studied peptides. F11A, particularly, was the most active in eliciting nodule formation, melanization and fat body activation, leading to a better control of yeast infection. Overall, the obtained data suggest a double role for F11A, able to simultaneously target the fungus and the host immune system, resulting in a more efficient pathogen clearance.<\/jats:p>","DOI":"10.3390\/ijms222010904","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T21:23:25Z","timestamp":1633901005000},"page":"10904","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Therapeutic Effect of an Antibody-Derived Peptide in a Galleria mellonella Model of Systemic Candidiasis"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3839-2698","authenticated-orcid":false,"given":"Emerenziana","family":"Ottaviano","sequence":"first","affiliation":[{"name":"Department of Health Sciences, University of Milan, 20142 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1893-0455","authenticated-orcid":false,"given":"Elisa","family":"Borghi","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Milan, 20142 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7514-1789","authenticated-orcid":false,"given":"Laura","family":"Giovati","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Falleni","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Milan, 20142 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6130-2665","authenticated-orcid":false,"given":"Delfina","family":"Tosi","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Milan, 20142 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Magliani","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Morace","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Milan, 20142 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9973-8352","authenticated-orcid":false,"given":"Stefania","family":"Conti","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6499-2545","authenticated-orcid":false,"given":"Tecla","family":"Ciociola","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Bongomin, F., Gago, S., Oladele, R.O., and Denning, D.W. (2017). Global and Multi-National Prevalence of Fungal Diseases\u2014Estimate Precision. J. Fungi., 3.","DOI":"10.3390\/jof3040057"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fmicb.2019.00214","article-title":"The Still Underestimated Problem of Fungal Diseases Worldwide","volume":"10","author":"Almeida","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e00449","DOI":"10.1128\/mBio.00449-20","article-title":"Threats Posed by the Fungal Kingdom to Humans, Wildlife, and Agriculture","volume":"11","author":"Fisher","year":"2020","journal-title":"mBio"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1126\/science.aaa6097","article-title":"How to bolster the antifungal pipeline","volume":"347","author":"Denning","year":"2015","journal-title":"Science"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/1040841X.2021.1876632","article-title":"What is the elephant in the room when considering new therapies for fungal diseases?","volume":"47","author":"Chaves","year":"2021","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Robbins, N., Wright, G.D., and Cowen, L.E. (2016). Antifungal Drugs: The Current Armamentarium and Development of New Agents. Microbiol. Spectr., 4.","DOI":"10.1128\/microbiolspec.FUNK-0002-2016"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"ofaa016","DOI":"10.1093\/ofid\/ofaa016","article-title":"Hope on the Horizon: Novel Fungal Treatments in Development","volume":"7","author":"Rauseo","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"ref_8","first-page":"e01719","article-title":"The Future of Antifungal Drug Therapy: Novel Compounds and Targets","volume":"65","author":"Dasilva","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/myc.13203","article-title":"Alternative treatment of fungal infections: Synergy with non-antifungal agents","volume":"64","author":"Rossato","year":"2021","journal-title":"Mycoses"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1007\/s00253-021-11407-7","article-title":"Drug repurposing strategies in the development of potential antifungal agents","volume":"105","author":"Zhang","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"foaa023","DOI":"10.1093\/femsyr\/foaa023","article-title":"The antifungal pipeline: The need is established. Are there new compounds?","volume":"20","author":"Li","year":"2020","journal-title":"FEMS Yeast Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.idc.2021.03.005","article-title":"Antifungals in Clinical Use and the Pipeline","volume":"35","author":"Johnson","year":"2021","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Waterer, G. (2021). Advances in anti-fungal therapies. Mycopathologia, 1\u20138.","DOI":"10.1007\/s11046-021-00560-2"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Basso, V., Tran, D.Q., Ouellette, A.J., and Selsted, M.E. (2020). Host Defense Peptides as Templates for Antifungal Drug Development. J. Fungi, 6.","DOI":"10.3390\/jof6040241"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2174\/18755305MTAxyMDAm5","article-title":"Clinical Applications of Antimicrobial Peptides (AMPs): Where do we Stand Now?","volume":"27","author":"Mithoor","year":"2020","journal-title":"Protein Pept. Lett."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3389\/fimmu.2020.00983","article-title":"Strategies in Translating the Therapeutic Potentials of Host Defense Peptides","volume":"11","author":"Ting","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/femsre\/fux012","article-title":"Perspectives for clinical use of engineered human host defense antimicrobial peptides","volume":"41","author":"Smani","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_18","first-page":"e02123","article-title":"Antimicrobial Peptides: A New Frontier in Antifungal Therapy","volume":"11","author":"Cristy","year":"2020","journal-title":"mBio"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2174\/1389557519666190926112423","article-title":"Recent Updates on Antifungal Peptides","volume":"20","author":"Deepika","year":"2020","journal-title":"Mini-Rev. Med. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fcimb.2020.00105","article-title":"Antifungal Peptides as Therapeutic Agents","volume":"10","author":"Arbulu","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","article-title":"Antimicrobial host defence peptides: Functions and clinical potential","volume":"19","author":"Mookherjee","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Li, T., Li, L., Du, F., Sun, L., Shi, J., Long, M., and Chen, Z. (2021). Activity and Mechanism of Action of Antifungal Peptides from Microorganisms: A Review. Molecules, 26.","DOI":"10.3390\/molecules26113438"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12275-021-0649-z","article-title":"Rediscovery of antimicrobial peptides as therapeutic agents","volume":"59","author":"Ryu","year":"2021","journal-title":"J. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1128\/AAC.47.2.643-652.2003","article-title":"MUC7 20-Mer: Investigation of antimicrobial activity, secondary structure, and possible mechanism of antifungal action","volume":"47","author":"Bobek","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1570-0232(03)00245-9","article-title":"Human hemoglobin-derived peptides exhibit antimicrobial activity: A class of host defense peptides","volume":"791","author":"Liepke","year":"2003","journal-title":"J. Chromatogr. B"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1042\/BJ20042099","article-title":"Candidacidal effects of two antimicrobial peptides: Histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane","volume":"388","author":"Bolscher","year":"2005","journal-title":"Biochem. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1128\/AAC.49.7.2583-2588.2005","article-title":"Different anti-Candida activities of two human lactoferrin-derived peptides, Lfpep and kaliocin-1","volume":"49","author":"Andres","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_28","first-page":"579","article-title":"Antimicrobial peptide MUC7 12-mer activates the calcium\/calcineurin pathway in Candida albicans","volume":"10","author":"Lis","year":"2010","journal-title":"FEMS Yeast Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1128\/EC.00095-14","article-title":"How does it kill? Understanding the candidacidal mechanism of salivary Histatin 5","volume":"13","author":"Puri","year":"2014","journal-title":"Eukaryot. Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.peptides.2015.07.023","article-title":"Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections","volume":"71","author":"Scarsini","year":"2015","journal-title":"Peptides"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Ciociola, T., Zanello, P.P., D\u2019Adda, T., Galati, S., Conti, S., Magliani, W., and Giovati, L. (2020). A peptide found in human serum, derived from the C-terminus of albumin, shows antifungal activity in vitro and in vivo. Microorganisms, 8.","DOI":"10.3390\/microorganisms8101627"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1007\/s00018-013-1260-1","article-title":"Properties and mechanisms of action of naturally occurring antifungal peptides","volume":"70","author":"Bleackley","year":"2013","journal-title":"Cell Mol. Life Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.4155\/fmc-2016-0035","article-title":"Natural and synthetic peptides with antifungal activity","volume":"8","author":"Ciociola","year":"2016","journal-title":"Future Med. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2217\/fmb.15.36","article-title":"Antibodies as a source of anti-infective peptides: An update","volume":"10","author":"Magliani","year":"2015","journal-title":"Future Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Ciociola, T., Giovati, L., Conti, S., and Magliani, W. (2021). Anti-Infective Antibody-Derived Peptides Active against Endogenous and Exogenous Fungi. Microorganisms, 9.","DOI":"10.3390\/microorganisms9010143"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Polonelli, L., Ciociola, T., Magliani, W., Zanello, P.P., D\u2019Adda, T., Galati, S., De Bernardis, F., Arancia, S., Gabrielli, E., and Pericolini, E. (2012). Peptides of the constant region of antibodies display fungicidal activity. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0034105"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Pertinhez, T.A., Ciociola, T., Giovati, L., Magliani, W., Belletti, S., Polonelli, L., Conti, S., and Spisni, A. (2018). Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19123792"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.meegid.2014.02.010","article-title":"The damage threshold hypothesis and the immune strategies of insects","volume":"24","year":"2014","journal-title":"Infect. Genet. Evol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Desalermos, A., Fuchs, B.B., and Mylonakis, E. (2012). Selecting an Invertebrate Model Host for the Study of Fungal Pathogenesis. PLOS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002451"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Pereira, T.C., de Barros, P.P., Fugisaki, L.R.O., Rossoni, R.D., Ribeiro, F.C., de Menezes, R.T., Junqueira, J.C., and Scorzoni, L. (2018). Recent Advances in the Use of Galleria mellonella Model to Study Immune Responses against Human Pathogens. J. Fungi., 4.","DOI":"10.3390\/jof4040128"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pharmthera.2018.10.008","article-title":"Antifungal drugs: New insights in research & development","volume":"195","author":"Nicola","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nri2939","article-title":"Immunity to fungal infections","volume":"11","author":"Romani","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1586\/14787210.5.6.1007","article-title":"Controlling pathogenic inflammation to fungi","volume":"5","author":"Romani","year":"2007","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1128\/EC.00067-15","article-title":"Acetylcholine Protects against Candida albicans Infection by Inhibiting Biofilm Formation and Promoting Hemocyte Function in a Galleria mellonella Infection Model","volume":"14","author":"Rajendran","year":"2015","journal-title":"Eukaryot. Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3109\/08820139.2011.615877","article-title":"Immunomodulatory Properties of Antifungal Agents on Phagocytic Cells","volume":"40","author":"Simitsopoulou","year":"2011","journal-title":"Immunol. Investig."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fphar.2019.00080","article-title":"The Yin and Yang of Current Antifungal Therapeutic Strategies: How Can We Harness Our Natural Defenses?","volume":"10","author":"Guerriero","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.3389\/fimmu.2020.02177","article-title":"Innate Inspiration: Antifungal Peptides and Other Immunotherapeutics from the Host Immune Response","volume":"11","author":"Mercer","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1111\/j.1742-4658.2009.07360.x","article-title":"Multifunctional host defense peptides: Antimicrobial peptides, the small yet big players in innate and adaptive immunity","volume":"276","author":"Auvynet","year":"2009","journal-title":"FEBS J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.4081\/ejh.2014.2428","article-title":"A histological procedure to study fungal infection in the wax moth Galleria mellonella","volume":"58","author":"Perdoni","year":"2014","journal-title":"Eur. J. Histochem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"ftaa062","DOI":"10.1093\/femspd\/ftaa062","article-title":"Activation of cellular immune response in insect model host Galleria mellonella by fungal \u03b1-1,3-glucan","volume":"78","author":"Wiater","year":"2020","journal-title":"Pathog. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e00689","DOI":"10.1128\/mSphere.00689-18","article-title":"Repurposing Pilocarpine Hydrochloride for Treatment of Candida albicans Infections","volume":"4","author":"Nile","year":"2019","journal-title":"mSphere"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1128\/AAC.01753-15","article-title":"Dissecting the Structure-Function Relationship of a Fungicidal Peptide Derived from the Constant Region of Human Immunoglobulins","volume":"60","author":"Ciociola","year":"2016","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/20\/10904\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:10:51Z","timestamp":1760166651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/20\/10904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,9]]},"references-count":52,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["ijms222010904"],"URL":"https:\/\/doi.org\/10.3390\/ijms222010904","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,9]]}}}